Gary A. Cain

854 total citations
19 papers, 555 citations indexed

About

Gary A. Cain is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gary A. Cain has authored 19 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gary A. Cain's work include Chemical Synthesis and Analysis (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Receptor Mechanisms and Signaling (3 papers). Gary A. Cain is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Receptor Mechanisms and Signaling (3 papers). Gary A. Cain collaborates with scholars based in United States and Germany. Gary A. Cain's co-authors include Robert A. Copeland, Ronald L. Magolda, William J. Pitts, June P. Davis, Philip Magnus, Mark R. DeLuca, Benjamin Mugrage, Thomas E. Christos, A.L. Johnson and Edward R. Holler and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Chemical Communications.

In The Last Decade

Gary A. Cain

17 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary A. Cain United States 11 261 192 63 63 54 19 555
Peter D. Gorycki United States 13 344 1.3× 146 0.8× 17 0.3× 116 1.8× 25 0.5× 29 735
Seong Heon Kim United States 12 284 1.1× 411 2.1× 25 0.4× 41 0.7× 63 1.2× 18 737
Yibin Zeng United States 15 208 0.8× 416 2.2× 34 0.5× 25 0.4× 18 0.3× 25 768
Masako Kuno Japan 14 291 1.1× 101 0.5× 47 0.7× 31 0.5× 63 1.2× 25 614
Neil Mathews United Kingdom 10 224 0.9× 159 0.8× 13 0.2× 16 0.3× 52 1.0× 14 504
Monish Jain United States 9 181 0.7× 169 0.9× 11 0.2× 30 0.5× 12 0.2× 17 525
Carl Crysler United States 19 304 1.2× 325 1.7× 14 0.2× 18 0.3× 29 0.5× 37 782
G. Müller Germany 10 176 0.7× 69 0.4× 87 1.4× 12 0.2× 17 0.3× 25 592
Hye-Ja Oh United States 13 471 1.8× 118 0.6× 32 0.5× 18 0.3× 10 0.2× 19 662
Robert B. McFadyen United States 13 279 1.1× 148 0.8× 18 0.3× 31 0.5× 25 0.5× 17 544

Countries citing papers authored by Gary A. Cain

Since Specialization
Citations

This map shows the geographic impact of Gary A. Cain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Cain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Cain more than expected).

Fields of papers citing papers by Gary A. Cain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Cain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Cain. The network helps show where Gary A. Cain may publish in the future.

Co-authorship network of co-authors of Gary A. Cain

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Cain. A scholar is included among the top collaborators of Gary A. Cain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Cain. Gary A. Cain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Arvanitis, Argyrios G., Richard G. Wilde, Gary A. Cain, et al.. (2003). Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands. Bioorganic & Medicinal Chemistry Letters. 13(1). 125–128. 11 indexed citations
3.
Cain, Gary A. & Edward R. Holler. (2001). Extended scope of in situ iodotrimethylsilane mediated selective reduction of benzylic alcohols. Chemical Communications. 1168–1169. 17 indexed citations
4.
Cain, Gary A. & James P. Beck. (2001). Unsymmetrical 4,6-Diamino-2-methyl-5-nitropyrimidine Synthesis via 4,6-Bis(tosylates). Heterocycles. 55(3). 439–439. 2 indexed citations
5.
Cain, Gary A. & Christopher A. Teleha. (2000). A CONVENIENT SYNTHESIS OF N-Boc-4-FORMYLPIPERINE. Organic Preparations and Procedures International. 32(1). 96–99. 2 indexed citations
6.
Cain, Gary A.. (2000). AN IMPROVED SYNTHESIS OF 3-CYANO-4-FLUOROBENZYL BROMIDE. Organic Preparations and Procedures International. 32(1). 88–91.
7.
Cain, Gary A., et al.. (2000). Sequential Benzylic Oxidation of Naloxone 3-Methyl Ether. Synthetic Communications. 30(24). 4513–4521. 6 indexed citations
8.
Batt, Douglas G., Joseph J. Petraitis, Gary A. Cain, et al.. (1999). Disubstituted Indazoles as Potent Antagonists of the Integrin αvβ3. Journal of Medicinal Chemistry. 43(1). 41–58. 63 indexed citations
9.
Davis, June P., Gary A. Cain, William J. Pitts, Ronald L. Magolda, & Robert A. Copeland. (1996). The Immunosuppressive Metabolite of Leflunomide Is a Potent Inhibitor of Human Dihydroorotate Dehydrogenase. Biochemistry. 35(4). 1270–1273. 239 indexed citations
10.
Cain, Gary A., Thomas E. Christos, Charles J. Eyermann, et al.. (1994). Novel conformationally restricted aromatic piperidines as selective sigma receptor ligands. Bioorganic & Medicinal Chemistry Letters. 4(2). 329–334. 1 indexed citations
11.
Christos, Thomas E., Gary A. Cain, A.L. Johnson, W. Schmidt, & S. William Tam. (1994). Novel ether derivatives of alkyl piperidines as potential sigma / 5HT2 antipsychotic agents. Bioorganic & Medicinal Chemistry Letters. 4(19). 2347–2352.
12.
Zaczek, Robert, et al.. (1993). Effects of linopirdine, HP 749, and glycyl‐prolyl‐glutamate on transmitter release and uptake. Drug Development Research. 29(3). 203–208. 15 indexed citations
13.
Cain, Gary A., Thomas E. Christos, A.L. Johnson, et al.. (1993). Neurotensin receptor binding and antinociceptive activity for lipophilic Nα-amido neurotensin(9–13) analogs. Bioorganic & Medicinal Chemistry Letters. 3(10). 2055–2060. 6 indexed citations
14.
Christos, Thomas E., Argyrios G. Arvanitis, Gary A. Cain, et al.. (1993). Stable isosteres of neurotensin c-terminal pentapeptides derived by modification of the amide function. Bioorganic & Medicinal Chemistry Letters. 3(6). 1035–1040. 17 indexed citations
15.
Gilligan, Paul J., Gary A. Cain, Thomas E. Christos, et al.. (1992). Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs. Journal of Medicinal Chemistry. 35(23). 4344–4361. 58 indexed citations
16.
Magnus, Philip, Benjamin Mugrage, Mark R. DeLuca, & Gary A. Cain. (1990). Studies on Gelsemium alkaloids. Total synthesis of (+)-koumine, (+)-taberpsychine, and (+)-koumidine. Journal of the American Chemical Society. 112(13). 5220–5230. 53 indexed citations
17.
Magnus, Philip, Benjamin Mugrage, Mark R. DeLuca, & Gary A. Cain. (1989). Total synthesis of (+)-koumine, (+)-taberpsychine, and (+)-koumidine. Journal of the American Chemical Society. 111(2). 786–789. 41 indexed citations
18.
White, D. R. & Gary A. Cain. (1989). The synthesis of trospectomycin (6′-n-propylspectinomycin, U-63,366f) from spectinomycin. Tetrahedron Letters. 30(12). 1469–1472. 3 indexed citations
19.
White, D. R., Clarence J. Maring, & Gary A. Cain. (1983). Synthesis and in vitro antibacterial properties of alkylspectinomycin analogs.. The Journal of Antibiotics. 36(3). 339–342. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026